Targeting diseases with unmet needs and significant public health burdens
Brii Bio began with a focus in infectious disease because the need is great in China and the threat is global. Infectious diseases are a leading cause of death and disability worldwide, contributing significantly to the increasing costs of health care.
Our passion for delivering world class research and technological innovation does not end here. We are taking aim at other diseases with significant unmet needs that have a dramatic impact on patients’ lives.
This includes diseases of the central nervous system. These disorders are among the most common in the world, affecting all countries. Emerging science has opened the door to novel ways to treat these diseases and our business model is strategically designed to identify transformative innovation and deliver it to patients.
Our goal is to pursue disease areas that present significant therapeutic challenges and, if there is the potential to redefine treatment and make a significant and unique contribution to health, Brii Bio will take a leadership role.